Grant Skrepnek to Urokinase-Type Plasminogen Activator
This is a "connection" page, showing publications Grant Skrepnek has written about Urokinase-Type Plasminogen Activator.
Connection Strength
0.078
-
Cost-effectiveness of urokinase and alteplase for treatment of acute peripheral artery disease: comparison in a decision analysis model. Am J Health Syst Pharm. 2008 Aug 01; 65(15):1435-42.
Score: 0.078